DOIAbstract
10.1016/S1570-0232(03)00399-4Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences7971-263-90JCBA
10.1016/S1570-0232(03)00399-4Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences7971-263-90JCBA
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Protein covalent labeling can be an undesirable property of compounds being studied in drug discover...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
Hemoglobin and serum albumin, two prevalent proteins in human blood, contain unbound cysteine thiol ...
The detection and characterization of chemical adducts on proteins is of increasing interest. Here, ...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Covalent binding of reactive metabolites of drugs to proteins has been a predominant hypothesis for ...
Protein covalent labeling can be an undesirable property of compounds being studied in drug discover...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
A variety of therapeutic drugs can undergo biotransformation via Phase I and Phase II enzymes to rea...
Protein covalent adducts formed upon exposure to reactive (mainly electrophilic) chemicals may lead ...
Hemoglobin and serum albumin, two prevalent proteins in human blood, contain unbound cysteine thiol ...
The detection and characterization of chemical adducts on proteins is of increasing interest. Here, ...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Covalent binding of reactive electrophilic intermediates to proteins is considered to play an import...
Add to ORKG